Camille Lobry

18PUBLICATIONS
103CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 31, 2026
ZMAT3 alleviates cell death in Fanconi anemia via adaptation of sphingolipid metabolism.

|Jul 08, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|May 07, 2026
Metabolic modulation of immune cell function: mechanisms and therapeutic implications in cancer immunotherapy.

|Jul 07, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nabih Maslah, Nina Kaci, Blandine Roux

|Jun 11, 2025
AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cells.

Khansa Saadallah, Benoît Vianay, Louise Bonnemay

|Oct 29, 2024
CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism.

Vincent Rondeau, Maria Kalogeraki, Lilian Roland

Pageof 3

Frequent Collaborators

6 joint publications

Alexandre Puissant

3 joint publications

Emmanuel Raffoux

3 joint publications

Raphael Itzykson

3 joint publications

Salima Benbarche